T1	Participants 136 158	advanced breast cancer
T2	Participants 210 262	155 consecutive patients with Stage IV breast cancer
T3	Participants 1048 1091	patients with more than one metastatic site
T4	Participants 1570 1610	estrogen receptor (ER)-negative patients
T5	Participants 1616 1653	patients younger than 51 years of age
T6	Participants 1663 1718	patients with a disease-free interval of 1 year or less
T7	Participants 1878 1898	ER-positive patients
T8	Participants 1947 1967	ER-negative patients
